WASHINGTON DC (May 24, 2019) — Today, the US Food and Drug Administration (FDA) permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint-infection (infection around a joint replacement) in the synovial (lubricant) fluid of patients being evaluated for revision surgery, which is surgery performed to replace or compensate for a failed implant.








